drugset / Trial / NCT00773201

Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation

NCT00773201

Phase 1 Completed 997 enrolled Assistance Publique - Hôpitaux de Paris
NaSingle-groupOpen-labelTreatment

Summary

The main objective is to research for genetic factors involved in the extreme modifications of the QT interval of the electrocardiogram in answer to a pharmacological stimulation (sotalol) and physiological stimulation in the apparently normal general population. The phenotypic characterization, based on the ventricular repolarisation dynamics will be used aiming at term of the predictive genetic factors of the acquired long QT syndrome

Timeline

Start
2008-02
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject sotalol Small molecule 80 mg Oral

Indications

No indication recorded.